@article{kim_impact_2014,
	title = {Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer},
	volume = {38},
	issn = {2210-741X},
	doi = {10.1016/j.clinre.2013.11.009},
	abstract = {BACKGROUND

Few studies have reported the relationship between MS and the prognosis of gastric cancer.


METHODS

Data were collected from 505 patients who underwent radical gastrectomy for gastric cancer between January 2006 and December 2007. After exclusion, remaining 204 patients were divided into two groups based on the presence of MS.


RESULTS

No significant differences were observed in tumor stage and grade between the MS (n=60) and non-MS (n=144) groups. The median follow-up periods were 53.2±23.5 and 54.7±22.1 months in for the MS and non-MS groups, respectively (P=0.677). Seventeen (28.3\%) and 21 (14.6\%) patients showed tumor recurrence in the MS and non-MS groups, respectively (P=0.022). In addition, disease-free survival of patients in the MS group was less than in non-MS group (P=0.036). The Cox regression hazard model demonstrated that advanced tumor stage (stage III or IV, HR=17.8, 95\% CI=5.3 to 59.4) and presence of MS (HR=2.8, 95\% CI=1.3 to 5.8) were independent risk factors for recurrence.


CONCLUSION

MS may be an important prognostic factor for gastric cancer. Control of MS could improve the therapeutic efficacy of gastric cancer.},
	number = {3},
	journal = {Clinics and research in hepatology and gastroenterology},
	author = {Kim, Eun Hye and Lee, Hyuk and Chung, Hyunsoo and Park, Jun Chul and Shin, Sung Kwan and Lee, Sang Kil and Hyung, Woo Jin and Lee, Yong Chan and Noh, Sung Hoon},
	month = jun,
	year = {2014},
	pmid = {24485596},
	keywords = {A1c, Metabolic Syndrome, insulin resistance, prognostic factors, survival},
	pages = {372--378},
}

{"_id":"ytSRfzmuW3jFAcWXE","bibbaseid":"kim-lee-chung-park-shin-lee-hyung-lee-etal-impactofmetabolicsyndromeononcologicoutcomeafterradicalgastrectomyforgastriccancer-2014","author_short":["Kim, E. H.","Lee, H.","Chung, H.","Park, J. C.","Shin, S. K.","Lee, S. K.","Hyung, W. J.","Lee, Y. C.","Noh, S. H."],"bibdata":{"bibtype":"article","type":"article","title":"Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer","volume":"38","issn":"2210-741X","doi":"10.1016/j.clinre.2013.11.009","abstract":"BACKGROUND Few studies have reported the relationship between MS and the prognosis of gastric cancer. METHODS Data were collected from 505 patients who underwent radical gastrectomy for gastric cancer between January 2006 and December 2007. After exclusion, remaining 204 patients were divided into two groups based on the presence of MS. RESULTS No significant differences were observed in tumor stage and grade between the MS (n=60) and non-MS (n=144) groups. The median follow-up periods were 53.2±23.5 and 54.7±22.1 months in for the MS and non-MS groups, respectively (P=0.677). Seventeen (28.3%) and 21 (14.6%) patients showed tumor recurrence in the MS and non-MS groups, respectively (P=0.022). In addition, disease-free survival of patients in the MS group was less than in non-MS group (P=0.036). The Cox regression hazard model demonstrated that advanced tumor stage (stage III or IV, HR=17.8, 95% CI=5.3 to 59.4) and presence of MS (HR=2.8, 95% CI=1.3 to 5.8) were independent risk factors for recurrence. CONCLUSION MS may be an important prognostic factor for gastric cancer. Control of MS could improve the therapeutic efficacy of gastric cancer.","number":"3","journal":"Clinics and research in hepatology and gastroenterology","author":[{"propositions":[],"lastnames":["Kim"],"firstnames":["Eun","Hye"],"suffixes":[]},{"propositions":[],"lastnames":["Lee"],"firstnames":["Hyuk"],"suffixes":[]},{"propositions":[],"lastnames":["Chung"],"firstnames":["Hyunsoo"],"suffixes":[]},{"propositions":[],"lastnames":["Park"],"firstnames":["Jun","Chul"],"suffixes":[]},{"propositions":[],"lastnames":["Shin"],"firstnames":["Sung","Kwan"],"suffixes":[]},{"propositions":[],"lastnames":["Lee"],"firstnames":["Sang","Kil"],"suffixes":[]},{"propositions":[],"lastnames":["Hyung"],"firstnames":["Woo","Jin"],"suffixes":[]},{"propositions":[],"lastnames":["Lee"],"firstnames":["Yong","Chan"],"suffixes":[]},{"propositions":[],"lastnames":["Noh"],"firstnames":["Sung","Hoon"],"suffixes":[]}],"month":"June","year":"2014","pmid":"24485596","keywords":"A1c, Metabolic Syndrome, insulin resistance, prognostic factors, survival","pages":"372–378","bibtex":"@article{kim_impact_2014,\n\ttitle = {Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer},\n\tvolume = {38},\n\tissn = {2210-741X},\n\tdoi = {10.1016/j.clinre.2013.11.009},\n\tabstract = {BACKGROUND\n\nFew studies have reported the relationship between MS and the prognosis of gastric cancer.\n\n\nMETHODS\n\nData were collected from 505 patients who underwent radical gastrectomy for gastric cancer between January 2006 and December 2007. After exclusion, remaining 204 patients were divided into two groups based on the presence of MS.\n\n\nRESULTS\n\nNo significant differences were observed in tumor stage and grade between the MS (n=60) and non-MS (n=144) groups. The median follow-up periods were 53.2±23.5 and 54.7±22.1 months in for the MS and non-MS groups, respectively (P=0.677). Seventeen (28.3\\%) and 21 (14.6\\%) patients showed tumor recurrence in the MS and non-MS groups, respectively (P=0.022). In addition, disease-free survival of patients in the MS group was less than in non-MS group (P=0.036). The Cox regression hazard model demonstrated that advanced tumor stage (stage III or IV, HR=17.8, 95\\% CI=5.3 to 59.4) and presence of MS (HR=2.8, 95\\% CI=1.3 to 5.8) were independent risk factors for recurrence.\n\n\nCONCLUSION\n\nMS may be an important prognostic factor for gastric cancer. Control of MS could improve the therapeutic efficacy of gastric cancer.},\n\tnumber = {3},\n\tjournal = {Clinics and research in hepatology and gastroenterology},\n\tauthor = {Kim, Eun Hye and Lee, Hyuk and Chung, Hyunsoo and Park, Jun Chul and Shin, Sung Kwan and Lee, Sang Kil and Hyung, Woo Jin and Lee, Yong Chan and Noh, Sung Hoon},\n\tmonth = jun,\n\tyear = {2014},\n\tpmid = {24485596},\n\tkeywords = {A1c, Metabolic Syndrome, insulin resistance, prognostic factors, survival},\n\tpages = {372--378},\n}\n\n","author_short":["Kim, E. H.","Lee, H.","Chung, H.","Park, J. C.","Shin, S. K.","Lee, S. K.","Hyung, W. J.","Lee, Y. C.","Noh, S. H."],"key":"kim_impact_2014","id":"kim_impact_2014","bibbaseid":"kim-lee-chung-park-shin-lee-hyung-lee-etal-impactofmetabolicsyndromeononcologicoutcomeafterradicalgastrectomyforgastriccancer-2014","role":"author","urls":{},"keyword":["A1c","Metabolic Syndrome","insulin resistance","prognostic factors","survival"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/groups/46698/items?key=ubq1R9YBMh4WxLV9o11xNG5E&format=bibtex&limit=100","dataSources":["cu4XGPYKkkiADwGRC"],"keywords":["a1c","metabolic syndrome","insulin resistance","prognostic factors","survival"],"search_terms":["impact","metabolic","syndrome","oncologic","outcome","radical","gastrectomy","gastric","cancer","kim","lee","chung","park","shin","lee","hyung","lee","noh"],"title":"Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer","year":2014}